Akero Therapeutics, Inc.

Bank of New York Mellon Corp AKRO

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/3/2025

Shares

236,089

Value ($000)

11,210

Weight

0.0%

2019 Q4 - 2025 Q3 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/3/2025	11,210	0.0%	236,089	9/30/2025
2025 Q2	8/5/2025	12,683	0.0%	237,683	6/30/2025
2025 Q1	4/29/2025	8,609	0.0%	212,665	3/31/2025
2024 Q4	2/4/2025	5,576	0.0%	200,430	12/31/2024
2024 Q3	11/12/2024	5,934	0.0%	206,844	9/30/2024
2024 Q2	7/25/2024	5,894	0.0%	251,234	6/30/2024
2024 Q1	4/25/2024	4,780	0.0%	189,246	3/31/2024
2023 Q4	1/29/2024	4,152	0.0%	177,795	12/31/2023
2023 Q3	10/24/2023	25,302	0.0%	500,245	9/30/2023
2023 Q2	8/3/2023	7,187	0.0%	153,928	6/30/2023
2023 Q1	5/9/2023	4,690	0.0%	122,592	3/31/2023
2022 Q4	2/14/2023	7,698	0.0%	140,482	12/31/2022
2022 Q3	11/14/2022	3,844	0.0%	112,890	9/30/2022
2022 Q2	8/15/2022	814	0.0%	86,077	6/30/2022
2022 Q1	5/11/2022	1,157	0.0%	81,582	3/31/2022
2021 Q4	2/11/2022	1,667	0.0%	78,789	12/31/2021
2021 Q3	11/18/2021	1,724	0.0%	77,114	9/30/2021
2021 Q2	8/11/2021	1,730	0.0%	69,721	6/30/2021
2021 Q1	5/13/2021	1,585	0.0%	54,648	3/31/2021
2020 Q4	2/9/2021	1,554	0.0%	60,232	12/31/2020
2020 Q3	11/12/2020	2,184	0.0%	70,928	9/30/2020
2020 Q2	8/12/2020	1,014	0.0%	40,688	6/30/2020
2020 Q1	5/6/2020	582	0.0%	27,456	3/31/2020
2019 Q4	2/14/2020	421	0.0%	18,968	12/31/2019